Data as of Apr 17
| +0.43 / +0.89%|
The 10 analysts offering 12-month price forecasts for AbbVie Inc have a median target of 56.50, with a high estimate of 61.00 and a low estimate of 44.00. The median estimate represents a +16.37% increase from the last price of 48.55.
The current consensus among 14 polled investment analysts is to Buy stock in AbbVie Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.